PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Imunami Laboratories Pte. Ltd.

USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2018–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Imunami ranks #40,880 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.

#40,880
of 49,997 US assignees by volume
6th percentile
by Innovation Score (19.6/100)
11.2
avg claims per patent
-80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40880 · Foreign Corporation #40,880 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 6 grants
  • LOWER-Q #40,880/49,997
  • PHOTO-FINISH Imnate Sarl
  • CPC-NARROW A61P · 3 areas
  • INNOV-LOW 19.6/100
  • CLAIMS-PAR 11.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -80% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Imnate Sarl (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Imunami’s 19.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Imunami

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Imunami's Innovation Score is 19.6/100 (6th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Imunami?

Each dot is one of Imunami’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Imunami’s own 11.2 claims/patent is at or below the 11.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Imunami vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 5.96.06.066.06.06.1 05101520 Granted patents (volume) Avg claims / patent Imnate Sarl - 6, 6.83Imnate SarlImpossible Diamond, Inc. - 6, 16.67Impossible DiamondImpress Group B.V. - 6, 12.17Impress Group B VImproved Racing Products, LLC - 6, 1Improved Racing P…InEVit LLC - 6, 19InevitInSyte Systems, Inc. - 6, 17.83Insyte SystemsIncuron, Inc. - 6, 11.17IncuronIndexator Rotator Systems AB - 6, 4.33Indexator Rotator…Imunami Laboratories Pte. Ltd. - 6, 11.17Imunami Laborator…
Imunami vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Imunami's grants concentrate

Imunami Laboratories Pte. Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2018. By volume, Imunami sits between Imnate Sarl and Indexator Rotator Systems AB.

Who files at Imunami's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Imunami holds 6 patents at rank #40,962, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Imunami

By rank, the assignees closest to #40,962 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Imunami's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Imunami, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Imunami ranks #2,984 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (20 here).

Jacuzzi Inc. 20 Think Tank Photo, Inc. 20 Wittenstein AG 20 Gymworld Inc. 20

Imunami's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

20 6th percentile higher than 6% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201820192020 1
USPTO utility patent grants by year · 2018–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Imunami Laboratories Pte. Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 16.7%
2019 4 66.7%
2020 1 16.7%

Which technologies does Imunami Laboratories Pte. Ltd. patent most?

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Imunami Laboratories Pte. Ltd.'s patent record in context - here's where to go next.

  • Imunami Laboratories Pte. Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #40,880 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Imunami Laboratories Pte. Ltd. against Imnate Sarl, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 19.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.